Nadia Soliha Zulkipli1*, Noor Nasirah Rosli2, Letchumi Raja Sureia2, Amelia Suhana Zamri1, Ahmad Afiq Haziq Abdullah1, Mohd Farid Baharin1
1. Primary Immunodeficiency Unit, Allergy and Immunology Research Centre (AIRC), Institute for Medical Research (IMR), National Institutes of Health (NIH), Ministry of Health, Malaysia
2. Paediatrics Unit, Hospital Tengku Ampuan Rahimah (HTAR), Ministry of Health, Malaysia.
*Corresponding author: Nadia Soliha Zulkipli.
ABSTRACT
INTRODUCTION: Bruton tyrosine kinase (BTK) is a critical cytoplasmic kinase involved in B-cell development, maturation, and signaling. Mutations in the BTK gene lead to X-linked agammaglobulinemia (XLA), a primary immunodeficiency characterized by markedly reduced or absent peripheral CD19+ B cells and very low levels of serum immunoglobulins. Affected individuals typically present in early childhood with recurrent bacterial infections due to impaired humoral immunity. Over 600 pathogenic variants in BTK have been identified, with most being missense, nonsense, or splice-site mutations. Here, we report a case of a BTK c.1921C>T mutation.
CASE REPORT: A 6-year-2-month-old boy had recurrent respiratory infections since infancy. He was hospitalized for pneumonia at 8 months and presumed meningitis at 1 year. From ages 1 to 4, he experienced frequent upper respiratory tract infections (URTIs). At 4 years, he developed lobar pneumonia, followed by multiple admissions for pneumonia and Pseudomonas aeruginosa bacteremia. At 5 years 3 months, he was treated for pneumonia with parapneumonic effusion and recurrent P. aeruginosa infections. Recently, chest radiograph revealed post-infectious bronchiolitis obliterans classes, prompting further investigations. Preliminary studies showed low immunoglobulin levels and absent CD19+ B cells. BTK flow cytometry revealed reduced level of BTK protein expression on monocytes. Sanger sequencing confirmed a BTK c.1921C>T (p.Arg641Cys) missense mutation, consistent with XLA, however, his mother is not a carrier of the mutation. Subsequently, he was started on intravenous immunoglobulin therapy.
CONCLUSION: Genetic diagnosis is essential for early detection of primary immunodeficiencies like XLA, allowing timely initiation of prophylactic treatment and prevention of complications. In this report, we identified a de novo BTK c.1921C>T (p.Arg641Cys) mutation, as the mother’s sequencing showed a wild-type variant. This report underscores the value of molecular testing in achieving accurate diagnosis, guiding clinical management, and facilitating genetic counseling.
KEYWORDS: Bruton Tyrosine Kinase, X-linked Agammaglobulinemia (XLA), Primary Immunodeficiency, Recurrent infections, Absent CD19+ B cells


